Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
Part of paid clinical trials in St Louis, Missouri.
- Sponsor
- Washington University School of Medicine
- Study ID
- NCT02841553
- Status
- Recruiting
Conditions
- Ataxia
- Deafness
- Diabetes Insipidus
- Diabetes Mellitus
- Optic Nerve Atrophy
- Wolfram Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
In this study, the investigators hypothesize that studying monogenic variants with strong effect associated with severe insulin deficiency of Wolfram syndrome will provide important insights into the more complex type 1 and type 2 diabetes mellitus. Aim 1. Establish and maintain a registry of patients with Wolfram syndrome. An Internet based registry will be employed to enroll participants with the clinical diagnosis of Wolfram syndrome (insulin dependent DM and bilateral OA). Clinical information regarding age of diagnosis and progression of the disease will be collated and analyzed to better define its natural history, along with potential metabolic phenotypes such as glucose intolerance of heterozygous parents and unaffected sibs. If not already completed, blood for WFS1 sequence analysis will be obtained on the participants (parents and sibs also for control purposes) and sent to a CLIA certified lab to define the mutation. This information will benefit patient families and referring physicians by providing a genetic diagnosis and where indicated. The Wolfram Syndrome Registry will foster international collaborations to more efficiently and systematically collect Wolfram syndrome patients and their clinical and experimental data.
Key Dates
- Start date
- Jul 31, 2011
- Status verified
- Dec 2025
- Primary completion
- Apr 30, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 5,000 participants (estimated)
Primary Outcome Measure
Changes in C-peptide levels in participants [ Time Frame: 10 years ]
Central Contacts
- Fumihiko Urano, MD(314) 477-1527
- Ashley Raterman, RN(314) 477-1527
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Washington University School of Medicine | St Louis | Missouri | 63110 | Fumihiko Urano, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in St Louis, MO
Related Studies
- Rare and Atypical Diabetes NetworkRecruiting · University of South Florida · Aurora, Colorado
- Impact GLP-1 Agonists Following BariatricPHASE4 · Recruiting · University of Missouri-Columbia · Columbia, Missouri
- A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPHASE2 · Recruiting · Children's Oncology Group · Mobile, Alabama
- Genetic Studies of Insulin and DiabetesRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland